Malaysia's New Health Minister Exclude GEG Clause in 2023 Smoking Control Bill

Regulations by 2FIRSTS.ai
Dec.14.2023
Malaysia's New Health Minister Exclude GEG Clause in 2023 Smoking Control Bill
Malaysia's new Health Minister, Dzulkefly Ahmad, apologizes for excluding the 'GEG' clause in the 2023 smoking control act.

According to a report by FMT on December 14th, Malaysia's newly appointed Health Minister, Dzulkefly Ahmad, has expressed his regret to the Parliament for excluding the Transgenerational Endgame of Generation Elimination (GEG) clause from the 2023 Public Health Tobacco Control Act.

 

When submitting the Public Health Smoking Products Control Bill for approval by the National Assembly, Zulkifli acknowledged the public's concerns regarding the inclusion of the GEG provision, which was intended to prohibit the sale of tobacco and e-cigarette products to individuals born after 2007.

 

Former Chairman of the Health Affairs Congressional Committee, Zou Jifei, was responsible for overseeing the adjustments to the bill. He explained that before the bill was finally passed by the House of Representatives on November 30th, various health ministers were involved in its formulation. He also stated that prior to the finalization of the bill, there were 18 stakeholder engagement meetings and three roundtable discussions.

 

I offer my sincerest apologies to all of you and earnestly implore you not to underestimate the significance of the bill, and to support its passage. It has undergone extensive development and has been in the making for a considerable period of time.

 

One of the goals of the GEG Bill is to prohibit the sale and purchase of tobacco products, smoking paraphernalia, tobacco alternatives, or the provision of smoking services to minors.

 

After intense debates in the parliament, the lower house has successfully passed the bill, leaving both sides disappointed with the removal of the GEG clause.

 

Earlier, the Attorney General of Malaysia, Ahmad Terluddin Saleh, mentioned that the GEG clauses had violated the rights under the law for equal protection. Dr. Zailah Mohd Yusoff, the former Minister of Health, stated that the government had decided to remove the GEG clauses in the revised version of the bill as they were unconstitutional.

 

However, she emphasized that the Ministry of Health has not abolished these regulations. On the contrary, she said it is only temporarily set aside "for now", and the government may reintroduce this law if there is a need in the future.

 

Despite claims that the Ministry of Health was under pressure from lobbyists and reluctant to include GEG clauses, Zalihah emphasized that there were no other factors involved except for the views of the Attorney General.

 

Zulkefi also commented that although the Health Affairs Congressional Committee and the Department of Health had hoped to include GEG provisions in the bill, it was deemed impossible by the Office of the Attorney General due to its potential violation of the Eighth Amendment of the Federal Constitution, which guarantees equal protection under the law.

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

U.S. CBP and FDA Seize 165,000 Illicit E-Cigarette Products; Total Value Exceeds $1.47 Million
U.S. CBP and FDA Seize 165,000 Illicit E-Cigarette Products; Total Value Exceeds $1.47 Million
U.S. Customs and Border Protection (CBP) seized approximately 165,000 illicit vaping products—including 90,000 e-cigarette devices and 75,000 refill cartridges—valued at over $1.47 million (MSRP). Following a joint assessment with the U.S. Food and Drug Administration (FDA), the products were deemed “adulterated and misbranded” for lacking required premarket authorization and were seized in accordance with the Federal Food, Drug, and Cosmetic Act (FD&C Act). The shipments, which featured multipl
Sep.30 by 2FIRSTS.ai
Bangladesh High Court Questions Legality of BEZA’s Approval for Philip Morris Nicotine Pouch Factory
Bangladesh High Court Questions Legality of BEZA’s Approval for Philip Morris Nicotine Pouch Factory
The High Court in Bangladesh has asked government bodies to explain why the approval granted to Philip Morris to establish a nicotine pouch factory should not be deemed illegal. Petitioners argue the decision contradicts existing policies and a 2016 Appellate Division ruling that restricts new tobacco-related enterprises. Authorities have ten days to respond.
Nov.20 by 2FIRSTS.ai
U.S. Lawmakers Seek to Empower HHS to Destroy Counterfeit Chinese Tobacco Products
U.S. Lawmakers Seek to Empower HHS to Destroy Counterfeit Chinese Tobacco Products
Bipartisan members of the U.S. Congress have introduced the “Ensuring the Necessary Destruction of Illicit Chinese Tobacco Act” (END Act), seeking to amend the Federal Food, Drug, and Cosmetic Act to authorize the Department of Health and Human Services (HHS) to directly destroy adulterated, misbranded, or counterfeit imported tobacco products.Major tobacco companies, including Altria, along with several public health organizations, have announced their support for the bill.
Nov.11 by 2FIRSTS.ai
Global Tobacco Companies’ Latest Earnings Review: Nicotine Pouch Business Shows Broad Strength, Emerging as a Key Growth Driver
Global Tobacco Companies’ Latest Earnings Review: Nicotine Pouch Business Shows Broad Strength, Emerging as a Key Growth Driver
Multiple global tobacco and next-generation nicotine companies reported solid Q3 performance, with the nicotine-pouch category showing broad-based strength across seven firms. Growth was reflected in higher shipment volumes, expanded market coverage, and new product launches. Several companies also reported rising revenue contributions from pouches and continued investment in this fast-growing segment, underscoring its position as a key driver of future growth.
Nov.14
ceshi1111
ceshi1111
Trusted by industry leaders and innovators, ARAC brings unmatched expertise in Modules 5 & 6, including label and claim development, comprehension testing, human factors/usability, and clinical-behavioral research such as actual use and switching studies. These studies generate the robust, real-world evidence needed to evaluate whether products are “Appropriate for the Protection of Public Health” (APPH) -- including randomized experimental longitudinal, actual use, cohort st
Oct.21
U.S FDA Announces Dec. 8 Deadline for IQOS MRTP Renewal Comments
U.S FDA Announces Dec. 8 Deadline for IQOS MRTP Renewal Comments
The U.S. FDA has set December 8, 2025, 11:59 p.m. ET as the closing date for public comments on the MRTP renewal applications submitted by Philip Morris Products S.A. for several IQOS heated tobacco products.
Nov.07 by 2FIRSTS.ai